ClinicalTrials.Veeva

Menu
K

Kalo Clinical Research | West Valley City, UT

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

JNJ-77242113
Eloralintide
LY3298176
Tirzepatide
LY3532226
Ustekinumab
Zenagamtide
Macupatide
Semaglutide
LY3841136

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

9 of 13 total trials

A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU) (EMBARQ-CSU2)

The purpose of this study is to establish the efficacy, safety and tolerability of barzolvolimab in adult participants with Chronic Spontaneous Urtic...

Active, not recruiting
Chronic Spontaneous Urticaria
Biological: Matching placebo
Biological: barzolvolimab

TRANSFORM is a prospective, randomized, open blinded endpoint (PROBE), event-driven, pragmatic trial in patients who are at increased risk for athero...

Enrolling
Diabetes Mellitus, Type 2
Metabolic Syndrome
Device: The Cleerly CAD Staging System

This clinical study is being conducted to evaluate the safety and effectiveness of zenagamtide in people with atherosclerotic cardiovascular disease...

Not yet enrolling
Obesity
Cardiovascular Risk
Drug: Zenagamtide
Drug: Placebo

The purpose of this study is to investigate the efficacy and safety of eloralintide and tirzepatide coformulation (EloraTZP) compared with tirzepatid...

Begins enrollment in 1 month
Obesity
Drug: Tirzepatide
Drug: Eloralintide

The purpose of the study is to evaluate how effective JNJ-77242113 is in participants with moderate to severe plaque psoriasis compared to placebo an...

Active, not recruiting
Plaque Psoriasis
Drug: Deucravacitinib Matching Placebo
Drug: JNJ-77242113 Matching Placebo

The purpose of this study is to investigate weight reduction with macupatide and eloralintide, alone or in combination, in adult participants with ob...

Active, not recruiting
Overweight
Obesity
Drug: Macupatide
Drug: Macupatide Placebo

This study will investigate the effect of tirzepatide on the reduction of morbidity and mortality in adults living with obesity and provide additiona...

Active, not recruiting
Overweight
Obesity
Drug: Placebo
Drug: Tirzepatide

The main purpose of this study is to assess how well JNJ-77242113 works when compared to placebo and ustekinumab in participants with moderate to sev...

Active, not recruiting
Plaque Psoriasis
Drug: Ustekinumab
Drug: Matching Placebo to Ustekinumab

The purpose of this extension study is to collect long-term efficacy and safety data on barzolvolimab in adult participants with Chronic Spontaneous...

Invitation-only
Chronic Spontaneous Urticaria
Biological: barzolvolimab
Other: Standard of Care

Trial sponsors

Lilly logo
Celldex Therapeutics logo
Janssen (J&J Innovative Medicine) logo
Novo Nordisk logo
AbbVie logo
C

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems